SIGA Technologies IncNASDAQ:SIGA
- LAST PRICE7.4700
- TODAY'S CHANGE (%)-0.1200 (-1.5810%)
- Bid / Lots7.4600/ 5
- Ask / Lots7.4700/ 1
- Open / Previous Close7.5900 / 7.5900
- Day Range
- 52 Week Range
- Volume151,727
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SIGA |
|---|---|---|
| 09:32 ET | 6404 | 7.59 |
| 09:34 ET | 5917 | 7.6872 |
| 09:36 ET | 1390 | 7.68 |
| 09:38 ET | 100 | 7.68 |
| 09:39 ET | 100 | 7.67 |
| 09:41 ET | 205 | 7.67 |
| 09:43 ET | 5865 | 7.62 |
| 09:48 ET | 100 | 7.61 |
| 09:50 ET | 190 | 7.6198 |
| 09:52 ET | 500 | 7.64 |
| 09:54 ET | 200 | 7.65 |
| 09:56 ET | 536 | 7.62 |
| 09:59 ET | 3078 | 7.655 |
| 10:01 ET | 3240 | 7.67 |
| 10:03 ET | 948 | 7.67 |
| 10:06 ET | 150 | 7.6707 |
| 10:10 ET | 10733 | 7.645 |
| 10:12 ET | 743 | 7.6399 |
| 10:15 ET | 100 | 7.6 |
| 10:17 ET | 9016 | 7.65 |
| 10:19 ET | 595 | 7.66 |
| 10:21 ET | 1100 | 7.62 |
| 10:26 ET | 450 | 7.63 |
| 10:28 ET | 800 | 7.63 |
| 10:30 ET | 895 | 7.62 |
| 10:32 ET | 200 | 7.6 |
| 10:35 ET | 844 | 7.59 |
| 10:37 ET | 100 | 7.59 |
| 10:42 ET | 300 | 7.56 |
| 10:44 ET | 1401 | 7.56 |
| 10:46 ET | 1518 | 7.54 |
| 10:48 ET | 122 | 7.5201 |
| 10:51 ET | 3405 | 7.545 |
| 10:57 ET | 483 | 7.55 |
| 11:00 ET | 493 | 7.5621 |
| 11:02 ET | 700 | 7.59 |
| 11:04 ET | 1600 | 7.5928 |
| 11:06 ET | 230 | 7.6 |
| 11:08 ET | 360 | 7.6005 |
| 11:09 ET | 637 | 7.595 |
| 11:13 ET | 427 | 7.6 |
| 11:15 ET | 1654 | 7.57 |
| 11:20 ET | 1936 | 7.55 |
| 11:22 ET | 100 | 7.54 |
| 11:24 ET | 1053 | 7.52 |
| 11:26 ET | 3310 | 7.51 |
| 11:27 ET | 600 | 7.5 |
| 11:29 ET | 667 | 7.5 |
| 11:31 ET | 100 | 7.5 |
| 11:33 ET | 100 | 7.51 |
| 11:36 ET | 5181 | 7.52 |
| 11:38 ET | 102 | 7.5057 |
| 11:40 ET | 100 | 7.51 |
| 11:42 ET | 100 | 7.515 |
| 11:44 ET | 207 | 7.54 |
| 11:45 ET | 350 | 7.512 |
| 11:47 ET | 100 | 7.52 |
| 11:49 ET | 200 | 7.51 |
| 11:51 ET | 100 | 7.51 |
| 11:54 ET | 200 | 7.51 |
| 11:56 ET | 200 | 7.5109 |
| 12:00 ET | 1100 | 7.52 |
| 12:02 ET | 262 | 7.52 |
| 12:05 ET | 100 | 7.52 |
| 12:12 ET | 700 | 7.5399 |
| 12:14 ET | 300 | 7.53 |
| 12:20 ET | 334 | 7.53 |
| 12:23 ET | 400 | 7.528 |
| 12:25 ET | 100 | 7.53 |
| 12:27 ET | 100 | 7.52 |
| 12:30 ET | 301 | 7.5216 |
| 12:32 ET | 1173 | 7.515 |
| 12:34 ET | 100 | 7.52 |
| 12:36 ET | 800 | 7.51 |
| 12:38 ET | 2255 | 7.51 |
| 12:39 ET | 265 | 7.5 |
| 12:41 ET | 100 | 7.5 |
| 12:43 ET | 200 | 7.49 |
| 12:50 ET | 200 | 7.48 |
| 12:54 ET | 320 | 7.47 |
| 12:56 ET | 700 | 7.46 |
| 12:57 ET | 435 | 7.47 |
| 12:59 ET | 200 | 7.46 |
| 01:01 ET | 190 | 7.4605 |
| 01:06 ET | 1625 | 7.46 |
| 01:10 ET | 300 | 7.47 |
| 01:12 ET | 1400 | 7.455 |
| 01:14 ET | 6050 | 7.46 |
| 01:15 ET | 3125 | 7.475 |
| 01:17 ET | 2438 | 7.45 |
| 01:19 ET | 2461 | 7.45 |
| 01:24 ET | 563 | 7.45 |
| 01:26 ET | 100 | 7.4576 |
| 01:28 ET | 1912 | 7.475 |
| 01:30 ET | 400 | 7.475 |
| 01:32 ET | 100 | 7.47 |
Jun 17, 2024
SIGA Announces Agreement to Sell TPOXX(R) to ASEAN Member States, from 4:05PM ET on Monday Jun 17, 2024 by Dow Jones
4:05PM ET on Monday Jun 17, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
SIGA Technologies Inc | 539.8M | 6.8x | -28.78% |
Harrow Inc | 739.1M | -23.1x | --- |
Esperion Therapeutics Inc | 420.6M | -2.4x | --- |
Bavarian Nordic A/S | 1.9B | 13.4x | --- |
Xeris Biopharma Holdings Inc | 333.6M | -4.7x | --- |
Takeda Pharmaceutical Co Ltd | 41.0B | 45.8x | -8.01% |
Company Information
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company focused on the health security market. Health security comprises countermeasures for biological, chemical, radiological and nuclear attacks, vaccines and therapies for emerging infectious diseases, and health preparedness. The Company's lead product is TPOXX, also known as tecovirimat and ST-246, an orally administered and intravenous (IV) formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. TPOXX is a novel small-molecule drug and the United States maintains a supply of TPOXX under Project BioShield. The European Medicines Agency and United Kingdom approvals include labeling for oral tecovirimat indicating its use for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications following vaccination against smallpox. It uses third parties known as contract manufacturing organizations to procure commercial raw materials and supplies, and to manufacture TPOXX.
Contact Information
- Headquarters
- 31 East 62Nd StreetNEW YORK, NY, United States 10065
- Phone
- 212-672-9100
- Fax
- 212-697-3130
Executives
- Chief Executive Officer, Director
- Diem Nguyen
- Chief Financial Officer, Executive Vice President, Corporate Secretary
- Daniel Luckshire
- Executive Vice President, Chief Scientific Officer
- Dennis Hruby
- Executive Vice President, Chief Medical Officer, Director
- Jay Varma
- General Counsel
- Lawrence Miller
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $539.8M |
|---|---|
Revenue (TTM) | $157.0M |
Shares Outstanding | 71.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.94 |
EPS | $1.10 |
Book Value | $2.77 |
P/E Ratio | 6.8x |
Price/Sales (TTM) | 3.4 |
Price/Cash Flow (TTM) | 6.8x |
Operating Margin | 61.78% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
